ReSearch Pharmaceutical Svcs.

ReSearch Pharmaceutical Services Inc. (RPS) provided comprehensive global Phase I-IV clinical development solutions to the pharmaceutical, biotechnology, medical device, and diagnostic industries. By combining its highly experienced clinical research operations infrastructure with the industry’s largest resourcing engines, RPS offered its customers a broad spectrum of outsourcing solutions ranging from globally embedded functional and cross-functional programs to enhanced global full-service solutions, powered by highly experienced project teams providing innovative, seamless, cost-effective, and high quality services. With more than 3,000 employees, RPS operated in 45 countries. PRA Health Sciences, now part of Icon (ICLR), acquired RPS in 2013.